Business Context and Reporting Period
This Form 6-K filing by AMBEV S.A. covers the period from February 1, 2025, to February 28, 2025. The report details transactions in securities and derivatives by the company's Board of Directors, Management, and Fiscal Council in compliance with Article 11 of CVM Instruction # 358/2002. The filing was signed on March 10, 2025.
Key Financial Metrics
This filing is a disclosure of insider trading activity and does not contain financial performance data such as revenue, profit, cash flow, margins, debt, or liquidity metrics. The filing text does not provide a clear value for any operational or financial KPIs.
Material Changes and Transactions
The filing reports specific transactions executed by Management personnel during the reporting month:
- Board of Directors: No transactions reported. Initial and final balances remained at 11,822,786 Common Shares and 1,244,220 ADRs.
- Management: Two sell transactions occurred on February 27, 2025:
- Sold 29,307 Common Shares via XP Corretora at R$ 12.03712 (Volume: R$ 352,772.00).
- Sold 50,000 Common Shares via Itaú Corretora at R$ 11.75000 (Volume: R$ 587,500.00).
- Management's Common Share balance decreased from 4,222,638 to 4,143,331. ADR holdings remained unchanged at 19,790.
- Fiscal Council: No transactions reported. Holdings remained at 0 Common Shares.
Guidance, Outlook, and Risks
The filing contains no management commentary, forward-looking guidance, risk factors, or discussion of contingencies. It is strictly a regulatory disclosure of security transactions.
Investor Verification Checklist
- Verify the total volume of shares sold by Management (79,307 shares) against the company's overall share count to assess dilution or insider sentiment.
- Confirm the transaction prices (R$ 11.75 - R$ 12.04) against the market price of AMBEV shares on February 27, 2025.
- Note that this filing does not replace quarterly or annual financial reports (Form 20-F) for operational performance analysis.